Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Prostate Cancer Prostatic Dis ; 6(2): 190-2, 2003.
Article in English | MEDLINE | ID: mdl-12806382

ABSTRACT

Minor hematochezia after transrectal ultrasound and prostate needle biopsy is well reported. We present a case report of a 64-yr-old man on aspirin and with poorly controlled hypertension who developed severe hematochezia requiring blood transfusion. The bleeding was stopped with digital compression. The literature on hemorrhagic complications after prostate needle biopsy is reviewed.


Subject(s)
Aspirin/therapeutic use , Biopsy, Needle/adverse effects , Gastrointestinal Hemorrhage/etiology , Gastrointestinal Hemorrhage/pathology , Platelet Aggregation Inhibitors/therapeutic use , Prostatic Neoplasms/pathology , Gastrointestinal Hemorrhage/therapy , Humans , Male , Middle Aged , Severity of Illness Index
2.
J Urol ; 166(5): 1651-7, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11586195

ABSTRACT

PURPOSE: We compare postoperative pain, stone-free rates and complications after ureteroscopic treatment of distal ureteral calculi with or without the use of ureteral stents. MATERIALS AND METHODS: A total of 113 patients with distal ureteral calculi amenable to ureteroscopic treatment were prospectively randomized into stented (53) and unstented (60) groups. Stones were managed with semirigid ureteroscopes with or without distal ureteral dilation and/or intracorporeal lithotripsy. Preoperative and postoperative pain questionnaires were obtained from each patient. Patients with stents had them removed 3 to 10 days postoperatively. Radiographic followup was performed postoperatively to assess stone-free rates and evidence of obstruction. RESULTS: Six patients randomized to the unstented group were withdrawn from the study after significant intraoperative ureteral trauma was recognized, including 3 ureteral perforations, that required ureteral stent placement, leaving 53 with stents and 54 without for analysis. Patients with stents had statistically significantly more postoperative flank pain (p = 0.005), bladder pain (p <0.001), urinary symptoms (p = 0.002), overall pain (p <0.001) and total narcotic use (p <0.001) compared to the unstented group. Intraoperative ureteral dilation or intracorporeal lithotripsy did not statistically significantly affect postoperative pain or narcotic use in either group (p >0.05 in all cases). Overall mean stone size in our study was 6.6 mm. There were 4 (7.4%) patients without stents who required postoperative readmission to the hospital secondary to flank pain. All patients (85%) who underwent imaging postoperatively were without evidence of obstruction or ureteral stricture on followup imaging (mean followup plus or minus standard deviation 1.8 +/- 1.5 months), and the stone-free rate was 99.1%. CONCLUSIONS: Uncomplicated ureteroscopy for distal ureteral calculi with or without intraoperative ureteral dilation can safely be performed without placement of a ureteral stent. Patients without stents had significantly less pain, fewer urinary symptoms and decreased narcotic use postoperatively.


Subject(s)
Pain, Postoperative , Stents , Ureteral Calculi/surgery , Ureteroscopy , Humans , Lithotripsy , Prospective Studies
5.
Urology ; 53(3): 647-52, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10096403

ABSTRACT

OBJECTIVES: Struvite calculus formation requires an alkaline urinary pH. An acidic urinary pH will dissolve struvite calculi and prevent recurrent struvite stone formation. Long-term urinary acidification has been unsuccessful. We sought to determine whether a gastric patch (with viable parietal cells) anastomosed to the renal pelvis could create an acidic urinary milieu. METHODS: A vascularized stomach patch (from the greater curvature) was anastomosed to the left renal pelvis in 15 female pigs. The right kidney was used as a control. The first 6 pigs were used to refine the surgical technique. The remaining 9 pigs were subjected to a formal gastropyeloplasty and followed up for 4 weeks. Urine was collected before and after stimulation with pentagastrin. Urine pH was measured from both kidneys in response to gastrin stimulation and oral intake. The kidneys, ureters, and bladders were examined for gross changes and histologic review. RESULTS: The 9 test animals had more acidic urine in the control kidney than in the gastropyeloplasty kidney. Pentagastrin had no significant impact on urinary pH. Hydroureteronephrosis and a concentrating defect were noted in the treated kidney. Histologic review revealed smooth muscle hyperplasia of the left ureter and viable parietal cells in the stomach patch. CONCLUSIONS: An animal model was developed to transfer a gastric patch to the renal pelvis. Hydronephrosis and ureteral dilation were associated with this gastric patch. We were unable to acidify the urine despite viable parietal cells in the transposed stomach segment. Further refinements of this concept may be successful in acidifying urine in the hope of preventing recurrent struvite nephrolithiasis.


Subject(s)
Kidney Pelvis/metabolism , Kidney Pelvis/surgery , Stomach/transplantation , Anastomosis, Surgical , Animals , Female , Hydrogen-Ion Concentration , Swine
7.
APMIS ; 106(1): 90-9; discussion 99-100, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9524567

ABSTRACT

The role of p53 in testicular germ cell tumours is still contradictory based on the finding of immunohistochemical overexpression at the protein level, but lack of mutations at the DNA level. In addition, p53 wild-type activity has been demonstrated in cell culture experiments. Overexpression of the proto-oncogene bcl-2 might block p53-induced apoptosis and might inhibit p53 functional activity. To clarify the apparent paradox with respect to p53 overexpression and lack of mutations, an immunohistochemical and mutational analysis of p53 and bcl-2 in TGCT was performed. Ten normal testes, 52 CIS and 151 clinical stage I nonseminomatous GCTs were included in our study. A commercially available anti-p53 polyclonal rabbit antibody and an anti-bcl-2-mouse monoclonal antibody were used to stain the 5pm sections. Staining was assessed by counting at least 500 cells from the area of the most intense staining in each tumour cell type, and this was scored semiquantitatively for intensity of staining on a 4 point scale. In addition, 30 primary GCTs were included in the mutational analysis: areas with p53 overexpression were identified and microdissected prior to DNA extraction. p53 exons 5-8 were amplified by polymerase chain reaction (PCR) followed by single strand conformation polymorphism analysis. Templates demonstrating band shifts on SSCP were subjected to direct DNA sequence analysis. None of the normal testes, 32/52 (62%) CIS, and 142/151 (94%) germ cell tumours exhibited p53 overexpression. p53 expression was significantly lower in mature teratomas (0.8 +/- 0.2) than in other germ cell tumour components (2.8 +/- 1.2, p > 0.001). PCR-SSCP did not reveal any missense mutations or deletions for the p53 gene. Bcl-2 protein expression was observed in none of the normal testes, in none of the CIS, and in 14/151 (9.3%) germ cell tumours. 13/14 germ cell tumours demonstrated bcl-2 expression only in the glandular and stromal elements of their teratomatous components whereas all other components were negative for bcl-2. Our results--p53 overexpression, lack of p53 mutations, undetectable bcl-2--are consistent with recent in vitro studies. High susceptibility of testicular cancer to drug-induced apoptosis appears to be the result of wild-type p53 and lack of bcl-2. Radiation and chemotherapeutic insensitivity of mature teratomas might be the result of bcl-2 overexpression and lack of p53 overexpression. Therefore, chemoresistance to DNA damaging agents might be reflected by the expression of p53 and bcl-2 and it might be useful to evaluate p53 and bcl-2 in primary tumours and metastatic lesions in order to identify patients early with primary or secondary chemoresistance.


Subject(s)
Germinoma/genetics , Mutation , Proto-Oncogene Proteins c-bcl-2/genetics , Testicular Neoplasms/genetics , Tumor Suppressor Protein p53/genetics , Animals , DNA Mutational Analysis , Genes, Tumor Suppressor , Genes, bcl-2 , Germinoma/metabolism , Humans , Immunohistochemistry , Male , Proto-Oncogene Mas , Proto-Oncogene Proteins c-bcl-2/analysis , Rabbits , Testicular Neoplasms/metabolism , Tumor Suppressor Protein p53/analysis
9.
J Urol ; 155(3): 982-5, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8583622

ABSTRACT

PURPOSE: We determined if immunohistochemical expression of the epidermal growth factor receptor and cathepsin D in the primary tumor was of prognostic value in clinically localized prostate cancer after radical prostatectomy. MATERIALS AND METHODS: Immunohistochemical staining for epidermal growth factor receptor and cathepsin D was performed on 105 radical prostatectomy specimens from 2 academic centers. The epidermal growth factor receptor and cathepsin D expressions were graded using H scoring by an experienced pathologist blinded to other patient data, and compared with age, grade, stage, race and initial serologic (prostate specific antigen) recurrence. Univariate and multivariate statistical testing was performed. RESULTS: Immunohistochemically detectable epidermal growth factor receptor and cathepsin D expression was not correlated to age, race, stage or Gleason grade. In univariate and multivariate testing epidermal growth factor receptor and cathepsin D were not prognostic markers for disease progression following radical prostatectomy. CONCLUSIONS: Immunohistochemical analysis of the biomarkers cathepsin D and epidermal growth factor receptor in radical prostatectomy specimens does not predict disease recurrence. Further biological marker study is needed in clinically localized prostate cancer.


Subject(s)
Cathepsin D/analysis , ErbB Receptors/analysis , Neoplasm Recurrence, Local/diagnosis , Prostatectomy , Prostatic Neoplasms/chemistry , Prostatic Neoplasms/diagnosis , Aged , Cathepsin D/biosynthesis , ErbB Receptors/biosynthesis , Humans , Immunohistochemistry , Male , Middle Aged , Multivariate Analysis , Predictive Value of Tests , Prognosis , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/surgery , Regression Analysis
11.
J Urol ; 154(2 Pt 1): 617-21, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7609148

ABSTRACT

PURPOSE: To determine if primary testicular germ cell tumors that overexpress p53 tumor suppressor gene protein have p53 gene mutations. MATERIALS AND METHODS: We examined 30 primary testicular tissues from 26 patients representing two groups. Group one consisted of eleven cases (6 nonseminomatous germ cell tumors and 5 seminomas) in which tissue samples for DNA analysis were microdissected from paraffin block regions with elevated immunohistochemical staining for p53 protein. Group two consisted of 19 testis tumor tissues which had been fresh frozen and were chosen to correspond to archival tissue specimens exhibiting elevated levels of p53 protein. The DNA was extracted from these tissues and subjected to exon specific amplification by polymerase chain reaction (PCR) and cold single-strand conformation polymorphism (Cold SSCP) analysis. RESULTS: In these cases with elevated p53 protein, no p53 gene exon 5-8 mutations were detected except 1 seminoma with a codon 140 silent mutation (no protein alteration). CONCLUSIONS: Testicular tumors appear to exhibit elevated levels of wild-type p53 protein, the significance of which is yet to be elucidated.


Subject(s)
Gene Expression Regulation, Neoplastic/genetics , Genes, p53/genetics , Germinoma/genetics , Testicular Neoplasms/genetics , Tumor Suppressor Protein p53/genetics , Base Sequence , Dissection , Germinoma/metabolism , Humans , Male , Molecular Sequence Data , Mutation , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , Testicular Neoplasms/metabolism , Tumor Suppressor Protein p53/biosynthesis
12.
J Urol ; 152(3): 946-7, 1994 Sep.
Article in English | MEDLINE | ID: mdl-8051762

ABSTRACT

Inverted Y duplication of the ureter is a rare anomaly. We report on a 24-year-old man who presented with urolithiasis and azoospermia in a solitary functioning kidney with an inverted Y ureteral duplication. To our knowledge our case represents the first documentation of ectopic emptying of 1 limb of the inverted Y ureter into the seminal vesicle. The embryology and management of this complex case are discussed.


Subject(s)
Seminal Vesicles/abnormalities , Ureter/abnormalities , Adult , Humans , Kidney/abnormalities , Male , Oligospermia/complications , Urinary Calculi/complications
13.
Urology ; 42(5): 593-5, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8236607

ABSTRACT

Synchronous bilateral testis tumors of different histologic types are rare. All previous cases have demonstrated germ cell tumors on both sides. The simultaneous appearance of a germ cell tumor and a contralateral non-germ cell tumor has not been reported. We herein report a thirty-four-year-old man who presented with a mixed non-seminomatous germ cell tumor of the left testis and theca cell tumor of the right testis.


Subject(s)
Germinoma/pathology , Neoplasms, Multiple Primary/pathology , Testicular Neoplasms/pathology , Thecoma/pathology , Adult , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...